Andrew Schutte, Director, Ten Percent Owner at RepliCel Life Sciences, holds 17.40M shares in RepliCel Life Sciences (Ticker: REPCF). Most recently, Andrew Schutte Bought $4,042,500 shares of RepliCel Life Sciences on Mar 15, 2023 for an estimated value of 404.25K.